E.E.S. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover E.e.s., and when can generic versions of E.e.s. launch?
E.e.s. is a drug marketed by Azurity and Arbor Pharms Llc and is included in four NDAs.
The generic ingredient in E.E.S. is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E.e.s.
A generic version of E.E.S. was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for E.E.S.
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Patent Applications: | 1,779 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for E.E.S. |
DailyMed Link: | E.E.S. at DailyMed |
Pharmacology for E.E.S.
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Anatomical Therapeutic Chemical (ATC) Classes for E.E.S.
US Patents and Regulatory Information for E.E.S.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | E.E.S. | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Azurity | E.E.S. | erythromycin ethylsuccinate | TABLET, CHEWABLE;ORAL | 050297-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 200 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-002 | Aug 12, 1982 | BX | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |